Update to Admission of Fundraising Shares
Cellbxhealth plc has provided an update on the admission of its fundraising shares, with First Admission of 9,090,000 First Tranche Fundraising Shares expected around December 16, 2025, and Second Admission for up to 770,910,000 Second Tranche Placing Shares, Subscription Shares, and Retail Offer Shares anticipated on December 18, 2025, subject to resolutions being passed.
Select text to share a quote on X · sign in to keep highlights & notes in your CLBX notes
CELLBXHEALTH plc (AIM: CLBX), a leader in circulating tumour cell (CTC) intelligence announces, following the conclusion of the oversubscribed Placing, the following update with regards Admission of the Fundraising Shares.
Subject to the passing of the Resolutions, First Admission will be in respect of 9,090,000 First Tranche Fundraising Shares and is expected to occur at 8.00 a.m. on or around 16 December 2025. Second Admission will be in respect of up to 770,910,000 Second Tranche Placing Shares, the Subscription Shares and the Retail Offer Shares and is expected to occur at 8.00 a.m. on 18 December 2025 (or, in each case, such later time and/or date as Cavendish and the Company and Cavendish may agree, not (being no later than 8.00 a.m. on 16 January 2026).
Capitalised terms used but not defined in this announcement have the meanings given to them in the Launch Announcement, unless context provides otherwise.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.